This page is provided for research and educational purposes only and does not provide medical advice, diagnosis, treatment recommendations, dosing instructions, or instructions for human use. Research findings should be interpreted within the population, model, formulation, route, outcomes, and study design reported by each cited source.
GHK-Cu (100 mg Vial)
GHK-Cu, or glycyl-L-histidyl-L-lysine copper complex, is a naturally occurring copper peptide studied for collagen-related pathways, tissue remodeling, antioxidant defense, and skin repair[7][8].
Quick Reference
What is GHK-Cu?
GHK-Cu is a copper–tripeptide complex. In an ex vivo study, researchers examined copper retention and penetration in isolated human skin after topical application of a GHK-Cu preparation[5]. This model does not establish a personal dose, syringe-unit conversion, or injection schedule.
Storage Instructions
Storage requirements should match the exact GHK-Cu preparation.
• Dry material: Follow the vial and batch documentation for temperature, moisture, and light protection[13].
• Prepared solution: Stability depends on concentration, pH, diluent, sterility, container, preservatives, and temperature.
• Handling: Minimize unnecessary light, moisture exposure, and repeated freeze-thaw cycles[13][14].
• Recordkeeping: Record the preparation date, concentration, storage temperature, and applicable disposal date.
How is GHK-Cu studied?
GHK-Cu is a naturally occurring copper-binding tripeptide studied in extracellular-matrix signaling, collagen-related pathways, antioxidant defense, and tissue remodeling[7][8]. Human studies provide topical and wound-care context[1][2][3][4][5], while an animal wound model provides local-administration context[6].
What does the research report about GHK-Cu?
Findings reported in the GHK-Cu research literature.
• Supports research into collagen-related signaling, extracellular-matrix remodeling, and tissue repair[6][7][8].
• Human topical and wound-care studies have examined skin and tissue outcomes in formulation-specific settings[1][2][3][4].
• Human-skin penetration research provides additional topical-delivery context[5].
• Observed findings depend on route, formulation, concentration, and study design; the supporting context is summarized in Important Notes above.
Research Limitations / Risk Notes
Published human GHK-Cu research has primarily evaluated topical and wound-care formulations[1][2][3][4][5], while local administration in an animal wound model provides additional preclinical context[6]. The cited human-skin penetration study used an ex vivo model and does not establish a personal subcutaneous administration schedule[5]. Current clinical-trial and FDA materials provide additional topical, compounding, and regulatory context[9][10][11][12].
Important Note
This content is provided for scientific research and educational purposes only. It does not provide medical advice, diagnosis, treatment, dosing, or administration instructions. The compounds discussed may be investigational and are not presented as approved for human use.
